AI Automation Demand And Margin Expansion Will Support Steady Performance Over Time

Catalysts

About UiPath

UiPath provides an automation and AI software platform that helps enterprises build, orchestrate and govern digital workflows.

What are the underlying business or industry changes driving this perspective?

• As more enterprises adopt AI-first operating models and accelerate cloud migration, UiPath’s reported cloud ARR of over US$1.2b and high AI product attachment among larger customers may support steadier subscription revenue and ARR over time.
• Although customer interest in agentic automation is helping AI product ARR reach nearly US$200 million, the company still depends on turning proof of concepts into scaled deployments, so the impact on total revenue and dollar-based net retention will hinge on how quickly these projects move beyond testing stages.
• While vertical solutions in healthcare revenue cycle workflows and financial crime compliance address heavily regulated areas where automation demand is present, execution risk around integrating WorkFusion and building repeatable use cases could influence the pace of ARR expansion and future RPO growth.
• Although AI coding agents are expected to shorten development cycles and increase automation capacity for customers, the benefit to UiPath depends on enterprises standardizing those agents on its platform rather than in-house or third-party tools, which will affect long-term ARR growth and platform-wide expansion.
• Despite UiPath’s focus on internal agent adoption and an updated long-term non-GAAP operating margin target of 30%, realizing those efficiency gains requires disciplined cost control and successful deployment of its own technology at scale, which will directly shape operating margins, GAAP profitability and adjusted free cash flow.

Assumptions

How have these above catalysts been quantified?

• This narrative explores a more pessimistic perspective on UiPath compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
• The bearish analysts are assuming UiPath's revenue will grow by 8.3% annually over the next 3 years.
• The bearish analysts assume that profit margins will increase from 17.5% today to 25.2% in 3 years time.
• The bearish analysts expect earnings to reach $514.9 million (and earnings per share of $0.64) by about May 2029, up from $282.3 million today. The analysts are largely in agreement about this estimate.
• In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 13.4x on those 2029 earnings, down from 19.1x today. This future PE is lower than the current PE for the US Software industry at 28.3x.
• The bearish analysts expect the number of shares outstanding to decline by 2.08% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 8.53%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

• If enterprises continue to adopt AI-first operating models and expand automation across more workflows, UiPath’s AI product ARR of nearly US$200 million and cloud ARR of over US$1.2b could support higher subscription demand than implied. This would feed into stronger revenue and ARR than a flat share price view assumes and ultimately affect earnings.
• UiPath has already reached US$1.853b of ARR, posted full year GAAP profitability for the first time and is targeting a long-term non-GAAP operating margin of 30%. Further operating efficiency or faster margin expansion than the bearish assumptions could put upward pressure on valuation multiples and earnings.
• High AI product attachment among larger customers, with 90% of customers over US$1 million in ARR and about 60% of customers over US$100,000 in ARR using AI products, creates an embedded expansion runway that could drive higher dollar-based net retention than expected and support stronger ARR and revenue growth.
• Vertical solutions in healthcare revenue cycle management, financial crime compliance via WorkFusion and growing public sector interest in long-term projects may give UiPath more high-value use cases than the current narrative allows for. This could increase ARR, improve net margins and raise earnings if these offerings scale successfully.
• Large partners such as Deloitte and Accenture are already building agentic solutions on top of UiPath’s platform. If these ecosystems keep driving bigger deployments like the 7 figure and US$20 million cost saving examples cited, that partner-driven demand could lift revenue and free cash flow above what a flat share price scenario implies.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bearish price target for UiPath is $10.98, which represents up to two standard deviations below the consensus price target of $13.5. This valuation is based on what can be assumed as the expectations of UiPath's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $17.0, and the most bearish reporting a price target of just $10.98.
• In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be $2.0 billion, earnings will come to $514.9 million, and it would be trading on a PE ratio of 13.4x, assuming you use a discount rate of 8.5%.
• Given the current share price of $10.27, the analyst price target of $10.98 is 6.5% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.